Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.
Atkins
Michael B
MB
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. matkins@bidmc.harvard.edu
Bukowski
Ronald M
RM
Escudier
Bernard J
BJ
Figlin
Robert A
RA
Hudes
Gary H
GH
Kaelin
William G
WG
Linehan
W Marston
WM
McDermott
David F
DF
Mier
James W
JW
Pedrosa
Ivan
I
Rini
Brian I
BI
Signoretti
Sabina
S
Sosman
Jeffrey A
JA
Teh
Bin Tean
BT
Wood
Christopher G
CG
Zurita
Amado J
AJ
King
Laura
L
D014408:Biomarkers, Tumor / Q000032:analysis; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D005544:Forecasting; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D011379:Prognosis
D014408:Biomarkers, Tumor